Revance Therapeutics | Vendas

Sales Alterar Data
AbbVie USD 12.31B 1.99B 2024-03
ALKERMES USD 350.4M 27.08M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
J&J USD 21.38B 15M 2024-03
Merck USD 15.8B 1.17B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
P&G USD 20.2B 1.24B 2024-03
Pacira USD 181.24M 17.32M 2023-12
Supernus Pharmaceuticals USD 164.31M 10.43M 2023-12



Revance Therapeutics Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2024.